Revenio Group Oyj announced iCare ILLUME, a screening solution using artificial intelligence, has been launched as part of iCare Solutions. iCare ILLUME is a unique combination of specialized screening software with artificial intelligence (AI) by partner Thirona and iCare DRSplus fundus imaging system with TrueColor Confocal capabilities. iCare ILLUME instantly detects signs of vision-threatening diabetic retinopathy with AI.
Retina images taken with the iCare DRSplus fundus imaging system are automatically transferred to iCare ILLUME solution cloud service and the report is instantly available. This allows the utilization of the high-quality images generated by the iCare DRSplus fundus imaging system even
more extensively as support for clinical decision-making. The iCare ILLUME solution can be used for screening other eye diseases in the future. iCare Solutions provides digital clinical tools that drive greater efficiency, enhance quality in eye care, and mean that health care professionals can provide care to a greater number of patients. iCare Solutions pairs high-quality fundus imaging systems and tonometers with intuitive, user-friendly, and secure clinical software. Digital tools that connect eye care pathways are the answer to increasing productivity while maintaining a high quality of care.